CRUSE MICHAEL (Senior VP, Corporate Operation) received a stock award from ONKURE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/14/2021ACC: 0001209191-21-069436
Officer· Senior VP, Corporate Operation
Since Apr 2021
+100K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
100K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
609.8%
12/10/2021
4.10K→29.10K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/10/2021 | A · Award | +25K | — | — | 609.8% | 4.10K | 29.10K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
75K shares
Shares
+75K
Strike price
6.69
Held after
75K
Exercisable
—
12/10/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock75K shares | 12/10/2021 | A · Award | +75K | 6.69 | — | 75K |